Novavax
NVAX
#5116
Rank
C$2.53 B
Marketcap
C$15.38
Share price
1.02%
Change (1 day)
53.98%
Change (1 year)

Novavax (NVAX) - Total assets

Total assets on the balance sheet as of June 2026 : C$1.34 Billion

According to Novavax's latest financial reports the company's total assets are C$1.34 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novavax - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31C$2.38 B-22.21%
2022-12-31C$3.06 B-6.67%
2021-12-31C$3.28 B62.75%
2020-12-31C$2.01 B793.25%
2019-12-31C$0.22 B-20.27%
2018-12-31C$0.28 B-25.51%
2017-12-31C$0.38 B-28.23%
2016-12-31C$0.52 B-1.05%
2015-12-31C$0.53 B67.19%
2014-12-31C$0.32 B27.97%
2013-12-31C$0.25 B145.93%
2012-12-31C$0.10 B50.28%
2011-12-31C$67.72 M-9.48%
2010-12-31C$74.81 M-16.94%
2009-12-31C$90.07 M-3.32%
2008-12-31C$93.16 M2.3%
2007-12-31C$91.07 M-35.82%
2006-12-31C$0.14 B44.44%
2005-12-31C$98.24 M4.87%
2004-12-31C$93.67 M-14.19%
2003-12-31C$0.10 B20.2%
2002-12-31C$90.82 M-15.05%
2001-12-31C$0.10 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
C$165.40 B 12,159.53%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$283.97 B 20,948.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$163.54 B 12,021.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$134.27 B 9,852.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$4.50 B 233.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$1.10 B-18.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$0.24 B-81.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
C$13.94 M-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$0.78 B-41.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.57 B 16.87%๐Ÿ‡บ๐Ÿ‡ธ USA